Towards early detection of Cancer
Project Title: Profiling of tumour derived microvesicles using an innovative multiplex microfluidic assay
(M3 PROFILER) .
The M3 PROFILER project aims to synergise the advantages of microfluidics, and multiplex bead based assays, to measure biomarkers in blood-derived exosomes (vesicles that originate from solid tumours). The project is funded under the FUSION program administered by the Malta Council for Science and Technology (MCST).
To develop a molecular test that measures COVID-19 (SARS-CoV-2) immune response for vaccine surveillance.
Innovative molecular profiling assays to classify tumours. We developed multiplex assays for academic research and lab based testing programs.
To innovate a companion diagnostic product that predicts use of specific therapeutics in Epilepsy.